Arvee Laboratories (India) Ltd Share Price & Stock Analysis

Arvee Laboratories (India) Ltd (NSE: ARVEE) is an Ahmedabad, Gujarat-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹251 Cr, it ranks #2,463 by market cap among the 6,197 Indian listed companies on FinBizNet, and #10 of 13 in Custom Synthesis and Specialty CDMO. At ₹222.00 (as of 16 Nov 2026), the share price is 23.7% below its 52-week high of ₹290.78 and 71.9% above its 52-week low of ₹129.11. The share price is up 39.6% over one year and up 31.6% over three months.

Key Metrics

Current Price₹222.00
Market Cap₹251 Cr
NSE SymbolARVEE
SectorMaterials > Chemicals > Speciality Chemicals
Sub-IndustrySpecialty Chemicals > Custom Synthesis and Specialty CDMO
P/E Ratio100
Return on Equity7.78%
Return on Assets3.07%
52-Week Range₹129.11 – ₹290.78
1-Year Price Change+39.6%
3-Month Price Change+31.6%
Beta (1Y)0.06
HeadquartersAhmedabad, Gujarat
Websitearveelabs.com

Latest Quarterly Results — Q2 FY27

Revenue₹25 Cr
Net Profit₹3 Cr
Net Margin10.3%
EPS (Basic)₹2.32
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Arvee Laboratories (India) Ltd Quarterly Revenue and Profit Trend

Arvee Laboratories (India) Ltd reported revenue of ₹25 Cr in Q2 FY27, up 622.6% from ₹3 Cr in Q2 FY26 and up 44.7% from ₹17 Cr in Q1 FY27. It posted a net profit of ₹3 Cr for the quarter, against a net profit of ₹0 Cr in Q2 FY26 (up 25500.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹3 Cr (Q2 FY26) to ₹25 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹25 Cr₹3 Cr10.3%
Q1 FY27₹17 Cr₹2 Cr9.8%
Q4 FY26₹11 Cr₹1 Cr4.8%
Q3 FY26₹10 Cr₹2 Cr18.7%
Q2 FY26₹3 Cr₹0 Cr0.3%
Q1 FY26₹7 Cr₹0 Cr2.3%
Q4 FY25₹6 Cr₹0 Cr1.1%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 73.50% of Arvee Laboratories (India) Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 63.3% of traded volume across 14 NSE sessions (22 Oct 2026 – 11 Nov 2026).

About Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.

Products and Services

1. Chemicals-This segment manufactures and sells various chemicals and pharmaceutical intermediates.

Business Segments

1. Chemicals-100%

Arvee Laboratories (India) Ltd vs Peers — Custom Synthesis and Specialty CDMO

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Anupam Rasayan India Ltd₹13,570 Cr79.65.76%₹806 Cr+20.1%
Neogen Chemicals Limited (Neogen)₹8,322 Cr259.23.58%₹296 Cr+93.4%
Prasol Chemicals Limited₹4,681 Cr58.1—₹413 Cr—
Laxmi Organic Industries Ltd₹4,574 Cr57.24.08%₹1,083 Cr-18.9%
Tatva Chintan Pharma Chem Ltd₹3,871 Cr92.55.53%₹217 Cr+12.2%
Paushak Ltd.₹1,487 Cr38.18.22%₹89 Cr—
Sunshield Chemicals Ltd.₹833 Cr25.217.02%—+12.6%
Chemcon Speciality Chemicals Limited₹733 Cr31.84.80%₹65 Cr-12.8%
Arvee Laboratories (India) Ltd₹251 Cr1007.78%₹25 Cr+39.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Arvee Laboratories (India) Ltd?

Arvee Laboratories (India) Ltd is trading at ₹222.00, with a market capitalisation of ₹251 Cr.

Which sector does Arvee Laboratories (India) Ltd belong to?

Arvee Laboratories (India) Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).

What are the key financial ratios of Arvee Laboratories (India) Ltd?

Arvee Laboratories (India) Ltd has a P/E of 100 and a return on equity of 7.78%.

What is the stock symbol of Arvee Laboratories (India) Ltd?

Arvee Laboratories (India) Ltd is listed on the NSE under the symbol ARVEE.

How has Arvee Laboratories (India) Ltd's share price moved over the past year?

Arvee Laboratories (India) Ltd's share price is up 39.6% over one year and up 31.6% over three months. Its 52-week range is ₹129.11 to ₹290.78.

What were Arvee Laboratories (India) Ltd's latest quarterly results?

In Q2 FY27, Arvee Laboratories (India) Ltd reported revenue of ₹25 Cr and net profit of ₹3 Cr, with basic EPS of ₹2.32 (standalone, parsed from the company's exchange filing).

How have Arvee Laboratories (India) Ltd's revenue and profit changed over the past year?

Arvee Laboratories (India) Ltd reported revenue of ₹25 Cr in Q2 FY27, up 622.6% from ₹3 Cr in Q2 FY26 and up 44.7% from ₹17 Cr in Q1 FY27.

What is the promoter holding in Arvee Laboratories (India) Ltd?

Promoters held 73.50% of Arvee Laboratories (India) Ltd's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.